Affiance Financial LLC increased its holdings in UnitedHealth Group Inc (NYSE:UNH) by 15.2% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,064 shares of the healthcare conglomerate’s stock after buying an additional 537 shares during the period. Affiance Financial LLC’s holdings in UnitedHealth Group were worth $883,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of UNH. North Star Investment Management Corp. purchased a new stake in shares of UnitedHealth Group in the third quarter worth $30,000. Griffin Asset Management Inc. purchased a new stake in shares of UnitedHealth Group in the second quarter worth $44,000. Coastal Capital Group Inc. purchased a new stake in shares of UnitedHealth Group in the second quarter worth $45,000. Capital Advisors Ltd. LLC increased its stake in UnitedHealth Group by 235.7% in the second quarter. Capital Advisors Ltd. LLC now owns 235 shares of the healthcare conglomerate’s stock valued at $57,000 after acquiring an additional 165 shares during the last quarter. Finally, Next Capital Management LLC bought a new position in UnitedHealth Group in the second quarter valued at $61,000. Institutional investors own 85.66% of the company’s stock.
UnitedHealth Group stock traded up $2.18 during trading hours on Friday, reaching $225.91. The company had a trading volume of 101,836 shares, compared to its average volume of 4,519,363. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.67 and a quick ratio of 0.67. The company has a 50-day moving average price of $227.48 and a 200 day moving average price of $240.20. The firm has a market cap of $208.59 billion, a price-to-earnings ratio of 17.52, a P/E/G ratio of 1.17 and a beta of 0.60. UnitedHealth Group Inc has a 12-month low of $208.07 and a 12-month high of $287.94.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.46 by $0.14. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. The firm had revenue of $60.60 billion during the quarter, compared to the consensus estimate of $60.59 billion. During the same quarter in the previous year, the company posted $3.14 earnings per share. The business’s revenue was up 8.0% on a year-over-year basis. As a group, research analysts expect that UnitedHealth Group Inc will post 14.83 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were given a $1.08 dividend. The ex-dividend date was Friday, September 13th. This represents a $4.32 annualized dividend and a yield of 1.91%. UnitedHealth Group’s payout ratio is currently 33.54%.
In other UnitedHealth Group news, Director Richard T. Burke sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $231.50, for a total value of $463,000.00. Following the completion of the sale, the director now owns 187,979 shares in the company, valued at $43,517,138.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Richard T. Burke sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $246.40, for a total value of $1,232,000.00. Following the completion of the sale, the director now owns 187,979 shares of the company’s stock, valued at approximately $46,318,025.60. The disclosure for this sale can be found here. Insiders sold 24,000 shares of company stock valued at $5,924,120 in the last quarter. Corporate insiders own 0.87% of the company’s stock.
A number of research analysts recently commented on the company. Cleveland Research reissued a “buy” rating on shares of UnitedHealth Group in a research note on Monday, July 15th. Morgan Stanley reduced their target price on UnitedHealth Group from $298.00 to $294.00 and set an “overweight” rating on the stock in a research note on Thursday, September 26th. Raymond James increased their target price on UnitedHealth Group from $265.00 to $300.00 and gave the company a “buy” rating in a research note on Friday, July 19th. Royal Bank of Canada set a $311.00 target price on UnitedHealth Group and gave the company a “buy” rating in a research note on Friday, July 19th. Finally, Credit Suisse Group set a $293.00 target price on UnitedHealth Group and gave the company a “buy” rating in a research note on Thursday, August 29th. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $283.78.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: What is dividend yield?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.